Publications
-
Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.
De Bruyne B,
Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, Jagic N, Möbius-Winkler S, Mobius-Winckler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engström T, Oldroyd KG, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Jüni P, Fearon WF.
N Engl J Med.
2012;
367
(11):
991-1001
-
Functional SYNTAX score for risk assessment in multivessel coronary artery disease.
Nam CW,
Mangiacapra F, Entjes R, Chung IS, Sels JW, Tonino PA, De Bruyne B, Pijls NH, Fearon WF.
J Am Coll Cardiol.
2011;
58
(12):
1211-8
-
Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease.
Fearon WF,
Bornschein B, Tonino PA, Gothe RM, Bruyne BD, Pijls NH, Siebert U.
Circulation.
2010;
122
(24):
2545-50
-
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention.
Tonino PA,
De Bruyne B, Pijls NH, Siebert U, Ikeno F, van' t Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF.
N Engl J Med.
2009;
360
(3):
213-24
-
Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction.
Fearon WF,
Shah M, Ng M, Brinton T, Wilson A, Tremmel JA, Schnittger I, Lee DP, Vagelos RH, Fitzgerald PJ, Yock PG, Yeung AC.
J Am Coll Cardiol.
2008;
51
(5):
560-5
-
Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) study.
Fearon WF,
Tonino PA, De Bruyne B, Siebert U, Pijls NH.
Am Heart J.
2007;
154
(4):
632-6
-
Invasive assessment of the coronary microcirculation: superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve.
Ng MK,
Yeung AC, Fearon WF.
Circulation.
2006;
113
(17):
2054-61
-
Physiologic assessment of renal artery stenosis: will history repeat itself?
Fearon WF,
J Am Coll Cardiol.
2006;
48
(9):
1856-8
-
Microvascular resistance is not influenced by epicardial coronary artery stenosis severity: experimental validation.
Fearon WF,
Aarnoudse W, Pijls NH, De Bruyne B, Balsam LB, Cooke DT, Robbins RC, Fitzgerald PJ, Yeung AC, Yock PG.
Circulation.
2004;
109
(19):
2269-72
-
Novel index for invasively assessing the coronary microcirculation.
Fearon WF,
Balsam LB, Farouque HM, Caffarelli AD, Robbins RC, Fitzgerald PJ, Yock PG, Yeung AC.
Circulation.
2003;
107
(25):
3129-32
-
Calculation of the index of microcirculatory resistance without coronary wedge pressure measurement in the presence of epicardial stenosis.
Yong AS,
Layland J, Fearon WF, Ho M, Shah MG, Daniels D, Whitbourn R, Macisaac A, Kritharides L, Wilson A, Ng MK.
JACC Cardiovasc Interv.
2013;
6
(1):
53-8
-
Fractional flow reserve assessment of left main stenosis in the presence of downstream coronary stenoses.
Yong AS,
Daniels D, De Bruyne B, Kim HS, Ikeno F, Lyons J, Pijls NH, Fearon WF.
Circ Cardiovasc Interv.
2013;
6
(2):
161-5
-
Physiologic approach for coronary intervention.
Fearon WF,
Korean J Intern Med.
2013;
28
(1):
1-7
-
ST-elevation myocardial infarction following heart transplantation as an unusual presentation of coronary allograft vasculopathy: a case report.
Peter S,
Hulme O, Deuse T, Vrtovec B, Fearon WF, Hunt S, Haddad F.
Transplant Proc.
2013;
45
(2):
787-91
-
Variability in quantitative and qualitative analysis of intravascular ultrasound and frequency domain optical coherence tomography.
Abnousi F,
Waseda K, Kume T, Otake H, Kawarada O, Yong CM, Fitzgerald PJ, Honda Y, Yeung AC, Fearon WF.
Catheter Cardiovasc Interv.
2013
-
Clinical and functional correlates of early microvascular dysfunction after heart transplantation.
Haddad F,
Khazanie P, Deuse T, Weisshaar D, Zhou J, Nam CW, Vu TA, Gomari FA, Skhiri M, Simos A, Schnittger I, Vrotvec B, Hunt SA, Fearon WF.
Circ Heart Fail.
2012;
5
(6):
759-68
-
Coronary microcirculatory resistance is independent of epicardial stenosis.
Yong AS,
Ho M, Shah MG, Ng MK, Fearon WF.
Circ Cardiovasc Interv.
2012;
5
(1):
103-8, S1-2
-
Most accurate definition of a high femoral artery puncture: aiming to better predict retroperitoneal hematoma in percutaneous coronary intervention.
Tremmel JA,
Tibayan YD, O'Loughlin AJ, Chan T, Fearon WF, Yeung AC, Lee DP.
Catheter Cardiovasc Interv.
2012;
80
(1):
37-42
-
The impact of downstream coronary stenoses on fractional flow reserve assessment of intermediate left main disease.
Daniels DV,
van't Veer M, Pijls NH, van der Horst A, Yong AS, De Bruyne B, Fearon WF.
JACC Cardiovasc Interv.
2012;
5
(10):
1021-5
-
The impact of sex differences on fractional flow reserve-guided percutaneous coronary intervention: a FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) substudy.
Kim HS,
Tonino PA, De Bruyne B, Yong AS, Tremmel JA, Pijls NH, Fearon WF.
JACC Cardiovasc Interv.
2012;
5
(10):
1037-42
-
The index of microcirculatory resistance predicts myocardial infarction related to percutaneous coronary intervention.
Ng MK,
Yong AS, Ho M, Shah MG, Chawantanpipat C, O'Connell R, Keech A, Kritharides L, Fearon WF.
Circ Cardiovasc Interv.
2012;
5
(4):
515-22
-
Comparison of drug-eluting versus bare metal stents in cardiac allograft vasculopathy.
Tremmel JA,
Ng MK, Ikeno F, Hunt SA, Lee DP, Yeung AC, Fearon WF.
Am J Cardiol.
2011;
108
(5):
665-8
-
Comparison of the frequency of coronary artery disease in alcohol-related versus non-alcohol-related endstage liver disease.
Patel S,
Kiefer TL, Ahmed A, Ali ZA, Tremmel JA, Lee DP, Yeung AC, Fearon WF.
Am J Cardiol.
2011;
108
(11):
1552-5
-
Impact of donor-transmitted atherosclerosis on early cardiac allograft vasculopathy: new findings by three-dimensional intravascular ultrasound analysis.
Yamasaki M,
Sakurai R, Hirohata A, Honda Y, Bonneau HN, Luikart H, Yock PG, Fitzgerald PJ, Yeung AC, Valantine HA, Fearon WF.
Transplantation.
2011;
91
(12):
1406-11
-
Is a myocardial infarction more likely to result from a mild coronary lesion or an ischemia-producing one?
Fearon WF,
Circ Cardiovasc Interv.
2011;
4
(6):
539-41
-
The index of microcirculatory resistance (IMR) in takotsubo cardiomyopathy.
Daniels DV,
Fearon WF.
Catheter Cardiovasc Interv.
2011;
77
(1):
128-31
-
Anatomic and functional evaluation of bifurcation lesions undergoing percutaneous coronary intervention.
Koo BK,
Waseda K, Kang HJ, Kim HS, Nam CW, Hur SH, Kim JS, Choi D, Jang Y, Hahn JY, Gwon HC, Yoon MH, Tahk SJ, Chung WY, Cho YS, Choi DJ, Hasegawa T, Kataoka T, Oh SJ, Honda Y, Fitzgerald PJ, Fearon WF.
Circ Cardiovasc Interv.
2010;
3
(2):
113-9
-
Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation.
Tonino PA,
Fearon WF, De Bruyne B, Oldroyd KG, Leesar MA, Ver Lee PN, Maccarthy PA, Van't Veer M, Pijls NH.
J Am Coll Cardiol.
2010;
55
(25):
2816-21
-
Balloon aortic valvuloplasty: modern indications and techniques for a niche therapy.
Yamen E,
Fearon WF.
Expert Rev Cardiovasc Ther.
2010;
8
(7):
885-7
-
Fractional flow reserve and myocardial perfusion imaging in patients with angiographic multivessel coronary artery disease.
Melikian N,
De Bondt P, Tonino P, De Winter O, Wyffels E, Bartunek J, Heyndrickx GR, Fearon WF, Pijls NH, Wijns W, De Bruyne B.
JACC Cardiovasc Interv.
2010;
3
(3):
307-14
-
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study.
Pijls NH,
Fearon WF, Tonino PA, Siebert U, Ikeno F, Bornschein B, van't Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, De Bruyne B.
J Am Coll Cardiol.
2010;
56
(3):
177-84
-
Impact of drug-eluting stent length on outcomes less is more...more or less.
Fearon WF,
JACC Cardiovasc Interv.
2010;
3
(2):
189-90
-
Intriguing peri-strut low-intensity area detected by optical coherence tomography after coronary stent deployment.
Teramoto T,
Ikeno F, Otake H, Lyons JK, van Beusekom HM, Fearon WF, Yeung AC.
Circ J.
2010;
74
(6):
1257-9
-
Long-term outcomes after percutaneous coronary intervention of left main coronary artery for treatment of cardiac allograft vasculopathy after orthotopic heart transplantation.
Lee MS,
Yang T, Fearon WF, Ho M, Tarantini G, Xhaxho J, Gerosa G, Weston M, Ehdaie A, Rabbani L, Kirtane AJ.
Am J Cardiol.
2010;
106
(8):
1086-9
-
Outcomes of percutaneous coronary intervention in intermediate coronary artery disease: fractional flow reserve-guided versus intravascular ultrasound-guided.
Nam CW,
Yoon HJ, Cho YK, Park HS, Kim H, Hur SH, Kim YN, Chung IS, Koo BK, Tahk SJ, Fearon WF, Kim KB.
JACC Cardiovasc Interv.
2010;
3
(8):
812-7
-
Quantitative assessment of coronary microvascular function in patients with and without epicardial atherosclerosis.
Melikian N,
Vercauteren S, Fearon WF, Cuisset T, MacCarthy PA, Davidavicius G, Aarnoudse W, Bartunek J, Vanderheyden M, Wyffels E, Wijns W, Heyndrickx GR, Pijls NH, de Bruyne B.
EuroIntervention.
2010;
5
(8):
939-45
-
Use of a low-profile, compliant balloon for percutaneous aortic valvuloplasty.
Yamen E,
Daniels DV, Van H, Yeung AC, Fearon WF.
Catheter Cardiovasc Interv.
2010;
75
(5):
794-8
-
Baseline fractional flow reserve and stent diameter predict optimal post-stent fractional flow reserve and major adverse cardiac events after bare-metal stent deployment.
Samady H,
McDaniel M, Veledar E, De Bruyne B, Pijls NH, Fearon WF, Vaccarino V.
JACC Cardiovasc Interv.
2009;
2
(4):
357-63
-
Expanding role of fractional flow reserve in the cardiac catheterization laboratory.
Fearon WF,
Expert Rev Cardiovasc Ther.
2009;
7
(5):
447-9
-
Safety and performance of targeted renal therapy: the Be-RITe! Registry.
Weisz G,
Filby SJ, Cohen MG, Allie DE, Weinstock BS, Kyriazis D, Walker CM, Moses JW, Danna P, Fearon WF, Sachdev N, Wiechmann BN, Vora K, Findeiss L, Price MJ, Mehran R, Leon MB, Teirstein PS.
J Endovasc Ther.
2009;
16
(1):
1-12
-
The pathophysiology and clinical course of the normal coronary angina syndrome (cardiac syndrome X).
Melikian N,
De Bruyne B, Fearon WF, MacCarthy PA.
Prog Cardiovasc Dis.
2008 Jan-Feb;
50
(4):
294-310
-
Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: modulation by sirolimus.
Potena L,
Fearon WF, Sydow K, Holweg C, Luikart H, Chin C, Weisshaar D, Mocarski ES, Lewis DB, Valantine HA, Cooke JP.
Transplantation.
2008;
85
(6):
827-33
-
Effect of rapamycin therapy on coronary artery physiology early after cardiac transplantation.
Sinha SS,
Pham MX, Vagelos RH, Perlroth MG, Hunt SA, Lee DP, Valantine HA, Yeung AC, Fearon WF.
Am Heart J.
2008;
155
(5):
889.e1-6
-
In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation.
Suzuki Y,
Ikeno F, Koizumi T, Tio F, Yeung AC, Yock PG, Fitzgerald PJ, Fearon WF.
JACC Cardiovasc Interv.
2008;
1
(2):
168-73
-
Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonist.
Fearon WF,
Fearon DT.
Circulation.
2008;
117
(20):
2577-9
-
Changes in coronary anatomy and physiology after heart transplantation.
Hirohata A,
Nakamura M, Waseda K, Honda Y, Lee DP, Vagelos RH, Hunt SA, Valantine HA, Yock PG, Fitzgerald PJ, Yeung AC, Fearon WF.
Am J Cardiol.
2007;
99
(11):
1603-7
-
Changes in coronary arterial dimensions early after cardiac transplantation.
Fearon WF,
Potena L, Hirohata A, Sakurai R, Yamasaki M, Luikart H, Lee J, Vana ML, Cooke JP, Mocarski ES, Yeung AC, Valantine HA.
Transplantation.
2007;
83
(6):
700-5
-
Determinants of lumen loss between years 1 and 2 after cardiac transplantation.
Sakurai R,
Yamasaki M, Nakamura M, Hirohata A, Honda Y, Bonneau HN, Luikart H, Yock PG, Fitzgerald PJ, Yeung AC, Valantine HA, Fearon WF.
Transplantation.
2007;
84
(9):
1097-102
-
Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation.
Biadi O,
Potena L, Fearon WF, Luikart HI, Yeung A, Ferrara R, Hunt SA, Mocarski ES, Valantine HA.
J Heart Lung Transplant.
2007;
26
(4):
324-30
-
Prognostic significance of PVCs and resting heart rate.
Engel G,
Cho S, Ghayoumi A, Yamazaki T, Chun S, Fearon WF, Froelicher VF.
Ann Noninvasive Electrocardiol.
2007;
12
(2):
121-9
-
Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection.
Potena L,
Holweg CT, Chin C, Luikart H, Weisshaar D, Narasimhan B, Fearon WF, Lewis DB, Cooke JP, Mocarski ES, Valantine HA.
Transplantation.
2006;
82
(3):
398-405
-
Discordant changes in epicardial and microvascular coronary physiology after cardiac transplantation: Physiologic Investigation for Transplant Arteriopathy II (PITA II) study.
Fearon WF,
Hirohata A, Nakamura M, Luikart H, Lee DP, Vagelos RH, Hunt SA, Valantine HA, Fitzgerald PJ, Yock PG, Yeung AC.
J Heart Lung Transplant.
2006;
25
(7):
765-71
-
Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology.
Kern MJ,
Lerman A, Bech JW, De Bruyne B, Eeckhout E, Fearon WF, Higano ST, Lim MJ, Meuwissen M, Piek JJ, Pijls NH, Siebes M, Spaan JA.
Circulation.
2006;
114
(12):
1321-41
-
Selective renal arterial infusion of fenoldopam for the prevention of contrast-induced nephropathy.
Ng MK,
Tremmel J, Fitzgerald PJ, Fearon WF.
J Interv Cardiol.
2006;
19
(1):
75-9
-
T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
Tu W,
Potena L, Stepick-Biek P, Liu L, Dionis KY, Luikart H, Fearon WF, Holmes TH, Chin C, Cooke JP, Valantine HA, Mocarski ES, Lewis DB.
Circulation.
2006;
114
(15):
1608-15
-
Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices.
Farouque HM,
Tremmel JA, Raissi Shabari F, Aggarwal M, Fearon WF, Ng MK, Rezaee M, Yeung AC, Lee DP.
J Am Coll Cardiol.
2005;
45
(3):
363-8
-
"Tako-tsubo-like left ventricular dysfunction": a clinical entity mimicking acute myocardial infarction with a favorable prognosis.
Farouque HM,
Kaltenbach T, Ako J, Tremmel JA, Fearon WF, Yeung AC, Vagelos RH.
Am J Geriatr Cardiol.
2004 Nov-Dec;
13
(6):
323-6
-
Epicardial stenosis severity does not affect minimal microcirculatory resistance.
Aarnoudse W,
Fearon WF, Manoharan G, Geven M, van de Vosse F, Rutten M, De Bruyne B, Pijls NH.
Circulation.
2004;
110
(15):
2137-42
-
Evaluation of high-pressure retrograde coronary venous delivery of FGF-2 protein.
Fearon WF,
Ikeno F, Bailey LR, Hiatt BL, Herity NA, Carter AJ, Fitzgerald PJ, Rezaee M, Yeung AC, Yock PG.
Catheter Cardiovasc Interv.
2004;
61
(3):
422-8
-
Pioglitazone-induced heart failure despite normal left ventricular function.
Shah M,
Kolandaivelu A, Fearon WF.
Am J Med.
2004;
117
(12):
973-4
-
The current and future role of percutaneous coronary intervention in patients with coronary artery disease.
Lipinski MJ,
Fearon WF, Froelicher VF, Vetrovec GW.
J Interv Cardiol.
2004;
17
(5):
283-94
-
Adjunctive platelet glycoprotein IIb/IIIa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes: results of the TIrofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) pilot trial.
Lee DP,
Herity NA, Hiatt BL, Fearon WF, Rezaee M, Carter AJ, Huston M, Schreiber D, DiBattiste PM, Yeung AC.
Circulation.
2003;
107
(11):
1497-501
-
Comparison of coronary thermodilution and Doppler velocity for assessing coronary flow reserve.
Fearon WF,
Farouque HM, Balsam LB, Caffarelli AD, Cooke DT, Robbins RC, Fitzgerald PJ, Yeung AC, Yock PG.
Circulation.
2003;
108
(18):
2198-200
-
Cost-effectiveness of measuring fractional flow reserve to guide coronary interventions.
Fearon WF,
Yeung AC, Lee DP, Yock PG, Heidenreich PA.
Am Heart J.
2003;
145
(5):
882-7
-
Evaluating intermediate coronary lesions in the cardiac catheterization laboratory.
Fearon WF,
Yeung AC.
Rev Cardiovasc Med.
2003;
4
(1):
1-7
-
Simultaneous assessment of fractional and coronary flow reserves in cardiac transplant recipients: Physiologic Investigation for Transplant Arteriopathy (PITA Study).
Fearon WF,
Nakamura M, Lee DP, Rezaee M, Vagelos RH, Hunt SA, Fitzgerald PJ, Yock PG, Yeung AC.
Circulation.
2003;
108
(13):
1605-10
-
A comparison of treadmill scores to diagnose coronary artery disease.
Fearon WF,
Gauri AJ, Myers J, Raxwal VK, Atwood JE, Froelicher VF.
Clin Cardiol.
2002;
25
(3):
117-22
-
Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry.
Pijls NH,
Klauss V, Siebert U, Powers E, Takazawa K, Fearon WF, Escaned J, Tsurumi Y, Akasaka T, Samady H, De Bruyne B.
Circulation.
2002;
105
(25):
2950-4
-
Clinical utility of the exercise ECG in patients with diabetes and chest pain.
Lee DP,
Fearon WF, Froelicher VF.
Chest.
2001;
119
(5):
1576-81
-
Effects of chronotropic incompetence and beta-blocker use on the exercise treadmill test in men.
Gauri AJ,
Raxwal VK, Roux L, Fearon WF, Froelicher VF.
Am Heart J.
2001;
142
(1):
136-41
-
Fractional flow reserve compared with intravascular ultrasound guidance for optimizing stent deployment.
Fearon WF,
Luna J, Samady H, Powers ER, Feldman T, Dib N, Tuzcu EM, Cleman MW, Chou TM, Cohen DJ, Ragosta M, Takagi A, Jeremias A, Fitzgerald PJ, Yeung AC, Kern MJ, Yock PG.
Circulation.
2001;
104
(16):
1917-22
-
Images in cardiology. Giant left ventricular pseudoaneurysm.
Fearon WF,
Lo S, Stertzer S.
Clin Cardiol.
2001;
24
(4):
345
-
Pneumocephalus due to invasive fungal sinusitis.
Engel G,
Fearon WF, Kosek JC, Loutit JS.
Clin Infect Dis.
2000;
30
(1):
215-7
-
The effect of resting ST segment depression on the diagnostic characteristics of the exercise treadmill test.
Fearon WF,
Lee DP, Froelicher VF.
J Am Coll Cardiol.
2000;
35
(5):
1206-11
-
Use of fractional myocardial flow reserve to assess the functional significance of intermediate coronary stenoses.
Fearon WF,
Takagi A, Jeremias A, Yeung AC, Joye JD, Cohen DJ, Chou TM, Kern MJ, Yock PG.
Am J Cardiol.
2000;
86
(9):
1013-4, A10
-
Does elevated cardiac troponin I in patients with unstable angina predict ischemia on stress testing?
Fearon WF,
Lee FH, Froelicher VF.
Am J Cardiol.
1999;
84
(12):
1440-2, A6, A8
-
Lessons learned from studies of the standard exercise ECG test.
Froelicher VF,
Fearon WF, Ferguson CM, Morise AP, Heidenreich P, West J, Atwood JE.
Chest.
1999;
116
(5):
1442-51
-
Iliofemoral venous thrombosis treated by catheter-directed thrombolysis, angioplasty, and endoluminal stenting.
Fearon WF,
Semba CP.
West J Med.
1998;
168
(4):
277-9
-
Should only the squeaky wheel get the grease? The prognostic significance of silent ischemia detected by exercise treadmill testing.
Fearon WF,
Voodi L, Atwood JE, Froelicher V.
Am Heart J.
1998;
136
(5):
759-61
-
Acute myocardial infarction in a young woman with systemic lupus erythematosus.
Fearon WF,
Cooke JP.
Vasc Med.
1996;
1
(1):
19-23
Navigation for This Section: Stanford Hospital & Clinics
Additional Links: Hospital Services
FIND A PHYSICIAN
Help